NCT04681105
- Conditions
- Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, Burkitt Lymphoma, +58 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Clinical trial condition
Refractory Hodgkin Lymphoma
Explore clinical trials studying Refractory Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.
34 public trials
5 recruiting studies
Refractory Hodgkin Lymphoma trial results
NCT02227199
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +8 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT03739619
- Conditions
- Classical Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +10 more
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Emory Saint Joseph's Hospital Atlanta, Georgia, United States
Completed
Ibrutinib and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
NCT02744612
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +8 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- NYP/Weill Cornell Medical Center New York, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT01701986
- Conditions
- Hematopoietic Cell Transplantation Recipient, Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT02824029
- Conditions
- Classical Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +9 more
- Locations
-
- University of Michigan Health System Ann Arbor, Michigan, United States
- Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
- University of Tennessee Knoxville, Tennessee, United States
- M D Anderson Cancer Center Houston, Texas, United States
NCT04052997
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +12 more
- Locations
-
- Mayo Clinic - Arizona Scottsdale, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- UCSF Health - Hematology and Blood and Marrow Transplant Clinic San Francisco, California, United States
- Stanford University Medical Center Stanford, California, United States
NCT03013933
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +8 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Completed
Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant
NCT02869633
- Conditions
- Blastoid Variant Mantle Cell Lymphoma, Chronic Disease, Disease Attributes, +27 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Stanford Cancer Institute Palo Alto, California, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
NCT02304458
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +53 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
- Children's Hospital of Orange County Orange, California, United States
- Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States